Developing New Strategies to Construct Pseudo-natural Macrocycles for Undruggable Targets
Han Wang1,2, Tongyu Bi1,2, Weibo Yang1,2
1State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Accounts of Chemical Research
|September 15, 2025
Summary
Researchers developed a modular biomimetic strategy to create pseudo-natural macrocycles for targeting undruggable proteins. This approach enables sustainable synthesis of diverse macrocycles for drug discovery, addressing challenges in treating complex diseases.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Drug Discovery
Background:
- Up to 85% of disease-related target proteins are undruggable, hindering therapeutic interventions.
- Macrocyclic compounds, particularly molecular glues, show promise for modulating these targets.
- Current macrocyclic drugs often originate from natural products, posing challenges in synthesis and availability.
Purpose of the Study:
- To develop innovative methodologies for constructing pseudo-natural macrocycles.
- To create a diverse library of pseudo-natural macrocycles for modulating undruggable targets.
- To highlight a modular biomimetic assembly strategy for rapid macrocycle generation.
Main Methods:
- Deconstructing natural product biosynthetic logic into programmable building blocks.
- Developing novel reactions to mimic natural bioactive building blocks.
- Replacing intricate chiral motifs with readily available amino acid derivatives.
Main Results:
- A modular biomimetic strategy enables rapid generation of diverse pseudo-natural macrocycles.
- Demonstrated applications include macrocyclic oximes for anti-influenza, spiro-fused macrocycles for Parkinson's disease, and macrocycles targeting protein-protein interactions for multidrug resistance.
- Structurally diverse, multifunctional bioactive pseudo-natural macrocycles can be produced concisely and sustainably.
Conclusions:
- The modular biomimetic strategy offers a sustainable and efficient approach to synthesize pseudo-natural macrocycles.
- This strategy holds significant potential for modulating undruggable targets and advancing drug discovery.
- Continued efforts in organic synthesis-driven medicinal chemistry can provide practical solutions for critical drug discovery challenges.
More Related Videos
Related Concept Videos
Targets for Drug Action: Overview
10.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.1K
Drug Discovery: Overview
11.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.1K
Prodrugs
4.0K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
4.0K
Cycloaddition Reactions: MO Requirements for Thermal Activation
4.3K
Thermal cycloadditions are reactions where the source of activation energy needed to initiate the reaction is provided in the form of heat. A typical example of a thermally-allowed cycloaddition is the Diels–Alder reaction, which is a [4 + 2] cycloaddition. In contrast, a [2 + 2] cycloaddition is thermally forbidden.
4.3K


